CN102319339A - A kind of Chinese medicine composition of treating senile fracture - Google Patents
A kind of Chinese medicine composition of treating senile fracture Download PDFInfo
- Publication number
- CN102319339A CN102319339A CN 201110292402 CN201110292402A CN102319339A CN 102319339 A CN102319339 A CN 102319339A CN 201110292402 CN201110292402 CN 201110292402 CN 201110292402 A CN201110292402 A CN 201110292402A CN 102319339 A CN102319339 A CN 102319339A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine composition of treating senile fracture, it is characterized in that it is made up of following bulk drugs: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae; 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis; 10-20 parts of Fructus Lyciis, 3-8 parts of SUNGU, 4-8 parts in Radix Glycyrrhizae; 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.The present invention combines the Therapeutic Method of replenishing QI and blood, invigorating the liver and kidney and bone and muscle strengthening, the treatment senile fracture, and curative effect is better, and cure rate is high, and few side effects makes the physiological function of human body be able to resume treatment purpose, and total effective rate is 96.9%.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of treating senile fracture, belong to the field of Chinese medicines.
Background technology
Fracture, the integrity of bone or seriality are damaged caused, serve as the disease that mainly shows with pain, swelling, livid purple, dysfunction, deformity and bony crepitus etc.
The treatment by oral administration of medicines of the traditional Chinese medical science after to fracture be divided into early, in, back three phases determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, adopt respectively attack accordingly and, mend three big method of treatment.Firm when injured human body the damage of QI and blood is arranged; Control blood during treatment and regulate the flow of vital energy and take into account; On behalf of prescription, method treatments such as eliminating blood stasis by catharsis commonly used, promoting flow of QI and blood, clearing away heat and cooling blood restore blood activating decoction: Radix Bupleuri, Radix Angelicae Sinensis, Flos Carthami, Squama Manis, Radix et Rhizoma Rhei (stir-fried with wine), wine Semen Persicae, Radix Trichosanthis.Damage mid-term; The stasis of blood is not gone to the greatest extent; Muscles and bones does not connect, should adopt and method, and be main with promoting regeneration of tissue by regulating nutrient QI, reunion of bone; Adopt method treatments such as relieving pain by regulating nutrient QI, reunion of bone, relaxing muscles and tendons and activating QI and blood in the collateral, representing prescription is that the synthetism Zijin is red: Eupolyphaga Seu Steleophaga, Olibanum, Myrrha, Pyritum, Rhizoma Drynariae, Radix Et Rhizoma Rhei, Sanguis Draxonis, Borax Radix Angelicae Sinensis etc.; Blood-activating bone-resetting soup: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Radix Rehmanniae, Flos Carthami, Rhizoma Drynariae, Eupolyphaga Seu Steleophaga, Pyritum (calcined), Radix Dipsaci, Herba sambuci chinensis, Olibanum, Myrrha etc.In the damage later stage, mostly the QI and blood loss is virtual image, adopts reinforcement, benefiting qi and nourishing blood commonly used, liver and kidney tonifying method, and representing prescription is decoction of ten powerful tonics: Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, the Radix Astragali, Cortex Cinnamomi; Chien pu hu chien wan: Cornu Cervi, Colla Plastri Testudinis, Radix Polygoni Multiflori, Radix Cyathulae, the Cortex Eucommiae, Herba Cynomorii etc.
The traditional Chinese medical science is thought, because old people's deficiency of the liver and kindey, muscles and bones is weak, and whole body skeletal bones amount reduces, and sclerotin is more loose than obviously with between twenty and fifty physiognomy, and it is slow to repair behind the bones and muscles injury.Therefore the treatment of senile fracture should be main with liver and kidney tonifying, QI and blood regulating, reunion of bone.
Summary of the invention
The object of the invention is exactly that a kind of Chinese medicine composition with method of treatment treatment senile fracture better curative effect, that combine invigorating the liver and kidney, replenishing QI and blood and bone and muscle strengthening will be provided.
The present invention is achieved in that by following bulk drugs and forms have better curative effect: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae; 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis; 10-20 parts of Fructus Lyciis, 3-8 parts of SUNGU, 4-8 parts in Radix Glycyrrhizae; 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
The weight portion of preferred each crude drug is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae, 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis, 15 parts of Fructus Lyciis, 5 parts of SUNGU, 6 parts in Radix Glycyrrhizae, 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Preparation technology uses " specification requirement of new Chinese medicine Study on Preparation " in principle; The effective constituent that mainly contains that uses modern preparation new technique to extract medicine is used as medicine; Add some accessory substances,, can be made into capsule, electuary, tablet, oral liquid like water, sugar, starch etc.
When this Chinese medicine composition was decocted in water for oral dose, every part was adopted gram to be unit, every day potion, decocting divides secondary oral, be 1 month the course of treatment, can reach the clinical cure effect.
The present invention combines the Therapeutic Method of replenishing QI and blood, invigorating the liver and kidney and bone and muscle strengthening, the treatment senile fracture, and curative effect is better, and cure rate is high, and few side effects makes the physiological function of human body be able to resume treatment purpose, and total effective rate is 96.9%.
The specific embodiment
The present invention is described further through clinical observation test and embodiment.
Test Example 1, clinical observation on the therapeutic effect data.
The treatment clinical method of senile fracture is a lot of, does not still have definite curative effect.We adopted the present invention to treat one group of case in nearly 3 years, obtained curative effect preferably, and existing report as follows.
1, clinical data.
1.1 physical data: this group amounts to 107 routine senile fracture patients and is my gate and examines and inpatient wherein male 57 examples, women 50 examples, 61～92 years old age.Diagnostic criteria with reference to " new Chinese medicine clinical research guideline " traditional Chinese medical science disease deficiency of qi and blood and caused by liver and kidney deficiency.At random all cases are divided into two groups, 64 examples are organized in treatment, male 35 examples, women 29 examples; Matched group 43 examples, male 22 examples, women 21 examples; Through statistical procedures, the difference nonsignificance has comparability at aspects such as sex, age, the course of disease, the state of an illness for two groups of patients.
1.2 Therapeutic Method: this is organized 107 routine patients and all adopts the bonesetting of traditional Chinese medical science traditional method, and maneuver is main to pull out, to stretch, and corrects wrong bone simultaneously in maneuver, plintlet or external plaster fixation, or bone traction.Matched group does not give the medicine of any promotion union of fracture, treats that it recovers naturally; The treatment group is a method of treatment with replenishing QI and blood, invigorating the liver and kidney and bone and muscle strengthening.Prescription adjusts accordingly in following scope endogenous cause of ill symptom: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae, 8-12 parts of Pyritums; 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis; 10-20 parts of Fructus Lyciis, 3-8 parts of SUNGU, 4-8 parts in Radix Glycyrrhizae; 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
Continuous use 1 month.During treating, encourage two groups of patients to carry out appropriate functional and take exercise, to increase local blood circulation, utilize the contractility of muscle on the limbs longitudinal axis, two fracture ends are combined closely etc.
1.3 curative effect determinate standard is according to disease curative effect determinate standard evaluation in " the clinical research guideline of new Chinese medicine treatment TF " in the Ministry of Public Health " new Chinese medicine clinical research guideline ".
1. produce effects: transference cure or disease integration reduce >=70%; 2. effective: symptom takes a turn for the better or the disease integration reduces >=30%,＜70%; 3. invalid: as not reach above standard person.
1.4 statistical method adopts
tThe check with
ⅹ 2Check.
2, result.
Two groups of patient's clinical efficacies compare, and produce effects 27 examples in 64 examples are organized in treatment, effective 35 examples, and invalid 2 examples, total effective rate is 96.9%; Produce effects 6 examples in matched group 43 examples, effective 18 examples, invalid 19 examples, total effective rate 55.8 %.Through statistical analysis, treatment group and matched group on clinical efficacy, exist extremely significant difference (
P＜0.01).
The present invention can further describe the present invention through following embodiment through the technology contents practical implementation of explaining in the summary of the invention, yet scope of the present invention is not limited to following embodiment.
Embodiment 1: getting each composition bulk drugs is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae, 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis, 15 parts of Fructus Lyciis, 5 parts of SUNGU, 6 parts in Radix Glycyrrhizae, 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Embodiment 2: getting each composition bulk drugs is: 8 parts of Radix Dipsacis, parasitic 12 parts, 8 parts of the Cortexs Eucommiae, 12 parts of Pyritums, 4 parts in Radix Notoginseng, 12 parts on mountain, bosom, 8 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lyciis, 3 parts of SUNGU, 8 parts in Radix Glycyrrhizae, 8 parts of Fructus Psoraleaes, 12 parts of Rhizoma Drynariae, 15 parts of Radix Pseudostellariaes.
Embodiment 3: getting each composition bulk drugs is: 12 parts of Radix Dipsacis, parasitic 8 parts, 12 parts of the Cortexs Eucommiae, 8 parts of Pyritums, 8 parts in Radix Notoginseng, 8 parts on mountain, bosom, 12 parts of Radix Angelicae Sinensis, 10 parts of Fructus Lyciis, 8 parts of SUNGU, 4 parts in Radix Glycyrrhizae, 12 parts of Fructus Psoraleaes, 8 parts of Rhizoma Drynariae, 25 parts of Radix Pseudostellariaes.
Embodiment 4: getting each composition bulk drugs is: 9 parts of Radix Dipsacis, parasitic 8 parts, 9 parts of the Cortexs Eucommiae, 9 parts of Pyritums, 5 parts in Radix Notoginseng, 9 parts on mountain, bosom, 11 parts of Radix Angelicae Sinensis, 18 parts of Fructus Lyciis, 6 parts of SUNGU, 7 parts in Radix Glycyrrhizae, 9 parts of Fructus Psoraleaes, 11 parts of Rhizoma Drynariae, 22 parts of Radix Pseudostellariaes.
Claims (2)
1. Chinese medicine composition of treating senile fracture is characterized in that it is made up of following bulk drugs: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae; 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis; 10-20 parts of Fructus Lyciis, 3-8 parts of SUNGU, 4-8 parts in Radix Glycyrrhizae; 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
2. a kind of Chinese medicine composition of treating senile fracture according to claim 1 is characterized in that the weight portion of each crude drug is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae; 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis; 15 parts of Fructus Lyciis, 5 parts of SUNGU, 6 parts in Radix Glycyrrhizae; 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110292402 CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110292402 CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102319339A true CN102319339A (en) | 2012-01-18 |
| CN102319339B CN102319339B (en) | 2013-03-13 |
Family
ID=45447264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110292402 Expired - Fee Related CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102319339B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813901A (en) * | 2012-08-27 | 2012-12-12 | 宋敏 | Preparation method of Chinese medicinal lotion treating insomnia type closed fractures |
| CN106266247A (en) * | 2016-11-14 | 2017-01-04 | 钱建荣 | A kind of compositions being applicable to treat lumbago |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
-
2011
- 2011-09-29 CN CN 201110292402 patent/CN102319339B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《陕西中医学院学报》 20101130 张世芳，等 中西医结合诊治老年人骨质疏松性骨折的研究进展 第145-147页 1-2 第33卷, 第6期 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813901A (en) * | 2012-08-27 | 2012-12-12 | 宋敏 | Preparation method of Chinese medicinal lotion treating insomnia type closed fractures |
| CN106266247A (en) * | 2016-11-14 | 2017-01-04 | 钱建荣 | A kind of compositions being applicable to treat lumbago |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102319339B (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103127378B (en) | Chinese medicinal composition for treating rheumatic heart disease | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN101249220A (en) | Oral capsule for curing cervicobrachia, lumbodynia and leg pain and method of preparing the same | |
| CN103006951B (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
| CN102319339B (en) | Chinese medicinal composition for treating senile fracture | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104173932A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103536760B (en) | Medicine for treating lumbar disc herniation | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN102813858B (en) | Traditional Chinese medicine for treating postpartum flooding by tonifying middle-jiao and vital energy | |
| CN102784212A (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN105663612A (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis | |
| CN106389943A (en) | Traditional Chinese medicinal composition for treating back myofascitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 344000 Fuzhou Hospital of traditional Chinese medicine, No. 240, Da Dao, Jiangxi, Fuzhou Patentee after: Li Hong Address before: 315032 1956 creative zone, transformer factory, Nanjing Road, Jiangbei District, Zhejiang, Ningbo Patentee before: Li Hong |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 Termination date: 20150929 |
|
| EXPY | Termination of patent right or utility model |